Cargando…
Manipulation of Regulatory Cells’ Responses to Treatments for Chronic Hepatitis B Virus Infection
BACKGROUND: Identification of effective treatments in hepatitis B virus (HBV) infection remains a controversial topic. Although the currently approved drugs for HBV control the disease’s progression and also limit associated outcomes, these drugs may not fully eradicate HBV infection. In addition to...
Autores principales: | Tavakolpour, Soheil, Alavian, Seyed Moayed, Sali, Shahnaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010887/ https://www.ncbi.nlm.nih.gov/pubmed/27630728 http://dx.doi.org/10.5812/hepatmon.37927 |
Ejemplares similares
-
Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review
por: Tavakolpour, Soheil, et al.
Publicado: (2016) -
Association of Plasma Levels of Vitamin D With Chronic Hepatitis B Infection
por: Tavakolpour, Soheil, et al.
Publicado: (2016) -
Comparison of Vitamin D Levels in Naive, Treated, and Inactive Carriers with Chronic Hepatitis B Virus
por: Sali, Shahnaz, et al.
Publicado: (2016) -
Real Response to Therapy in Chronic Hepatitis C Virus Patients: A Study From Iran
por: Namazee, Najmeh, et al.
Publicado: (2012) -
Tumor Necrosis Factor-α-308 G/A Polymorphisms and Risk of Hepatocellular Carcinoma: A Meta-Analysis
por: Tavakolpour, Soheil, et al.
Publicado: (2016)